Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders
NCT00051337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2008-03-04
Summary
This study will use single photon emission computed tomography (SPECT) to determine what areas of the brain are responsible for paroxysmal hyperkinetic movement disorders. Patients with these disorders have sudden, brief attacks of movement, similar to epileptic seizures, but without loss of consciousness. SPECT is a nuclear medicine test that produces three-dimensional images of the brain, showing blood flow and function in different brain regions. This test, which can detect the focus of epileptic seizures, will be used in this study to scan patients while they are experiencing a hyperkinetic movement attack, while they are not having and attack, and while they are simulating an attack.
Patients 18 years of age and older who have paroxysmal movement attacks that can be easily induced by a specific trigger, such as a sudden movement or prolonged exercise, may be eligible for this study. Candidates will be screened with a medical history and review of their medical records, physical examination, videotape of attacks, and, for women, a pregnancy test.
Participants will have three SPECT scans, separated from each other by at least 48 hours. Before each scan, the subject will perform an activity that ordinarily precipitates a movement attack, such as standing up from a chair, assuming a certain posture, or doing something strenuous. Each scan will try to record one of the following conditions:
* The subject performs the trigger activity, but does not have an attack;
* The subject performs the trigger activity and has an involuntary attack as a result;
* The subject performs the trigger activity and does not have an attack, but then mimics an attack voluntarily.
After the condition is recorded, the subject will be given an injection of a radioactive agent called 99m Technetium and will then relax quietly for 40 to 60 minutes before the SPECT scan. For the scan, the subject lies on an examination table and the SPECT camera is moved near and around the head to image the brain. The scan takes about 40 minutes.
Participants will also undergo one magnetic resonance imaging (MRI) scan. For this test, the subject lies in a narrow cylinder (the scanner), while pictures of the brain are taken. Earplugs are worn to muffle loud noises caused by electrical switching of radio frequency circuits used in the scanning process. The procedure takes about 30 minutes.
Conditions
- Hyperkinesis
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Completion
- 2005-01-31
Countries
- United States
Study Locations
More Related Trials
-
Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia
NCT05164705 ·Status: COMPLETED ·Phase: NA
-
Molecular and Functional Imaging in Monogenic PD.
NCT05518617 ·Status: RECRUITING
-
PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency
NCT00246870 ·Status: COMPLETED
-
The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus
NCT06017973 ·Status: RECRUITING ·Phase: NA
-
PET Scan in Patients With Neurocardiologic Disorders
NCT00001418 ·Status: COMPLETED
-
Establish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan® in Cadmium-Zinc-Telluride Camera
NCT06828705 ·Status: NOT_YET_RECRUITING
-
PET Scan to Map the Areas of the Brain Involved in Planning
NCT00001363 ·Status: COMPLETED
-
Imaging Study of Automatic Movements
NCT00031382 ·Status: COMPLETED
-
Brain Blood Flow Studies of Language and Memory
NCT00001288 ·Status: COMPLETED
-
Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI)
NCT01021137 ·Status: COMPLETED
-
Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem
NCT02090855 ·Status: COMPLETED
-
Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study
NCT05753995 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients
NCT00427674 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)
NCT00001845 ·Status: COMPLETED
-
PET Scans in Normal Volunteers and Patients With Fabry Disease
NCT00005111 ·Status: COMPLETED
-
Neocortical Epilepsies - Do They Progress?
NCT00610558 ·Status: COMPLETED ·Phase: NA
-
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
NCT00613119 ·Status: COMPLETED
-
Brain Imaging in Children With AD/HD
NCT00008892 ·Status: COMPLETED
-
A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection
NCT00576147 ·Status: COMPLETED ·Phase: NA
-
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NCT04141150 ·Status: UNKNOWN ·Phase: PHASE2
-
Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury
NCT01044615 ·Status: COMPLETED
-
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
NCT03270059 ·Status: RECRUITING ·Phase: PHASE2
-
Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2
NCT02556177 ·Status: COMPLETED ·Phase: NA
-
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577 ·Status: RECRUITING
-
Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines
NCT02385877 ·Status: COMPLETED ·Phase: EARLY_PHASE1